Search bioRxivSearch

bioRxiv · 10.1101/206342

An olfactogenetic approach identifies olfactory neurons and brain centers directing negative oviposition decisions in Drosophila.

Abstract

The sense of smell influences behaviors in animals, yet how odors are represented in the brain remains unclear. The nose contains different types of olfactory sensory neurons (OSNs), each expressing a particular odorant receptor, and OSNs expressing the same receptors converge their axons on a brain region called a glomerulus. In Drosophila, second order neurons (projection neurons) typically innervate a single glomerulus and send stereotyped axonal projections to the lateral horn. One of the greatest challenges to studying olfaction is the lack of methods allowing activation of specific types of olfactory neurons in an ethologically relevant setting. Most odorants activate many olfactory neurons, and many olfactory neurons are activated by a variety of odorants. As such, it is difficult to identify if individual types of olfactory neurons directly influence a behavior. To address this, we developed a genetic method in Drosophila called olfactogenetics in which a narrowly tuned odorant receptor, Or56a, is ectopically expressed in different olfactory neuron types. Stimulation with geosmin (the only known Or56a ligand), in an Or56a mutant background leads to specific activation of only the target olfactory neuron type. We used this approach to identify which types of olfactory neurons can directly guide oviposition decisions. We identified 5 OSN-types (Or71a, Or47b, Or49a, Or67b, and Or7a) that, when activated alone, suppress oviposition. Projection neurons partnering with these OSNs share a region of innervation in the lateral horn, suggesting that oviposition site-selection might be encoded in this brain region.\n\nSignificance StatementThe sense of smell begins by activation of olfactory neurons in the nose. These neurons express an olfactory receptor that binds odorants (volatile chemicals). How the sense of smell is encoded in the brain remains unclear. A key challenge is due to the nature of olfactory receptors themselves - most respond to a wide range of odorants - so it is often impossible to activate just a single olfactory neuron type. We describe here a novel approach in Drosophila called olfactogenetics which allows the specific experimental activation of any desired olfactory neuron. We use olfactogenetics to identify olfactory neurons and brain regions that guide egg-laying site selection. Olfactogenetics could be a valuable method to link olfactory neuron activities with circuits and behaviors.

Explore related subjects

Keep this discovery

BibTeXRIS

Chin, S. G., Maguire, S. E., Huoviala, P., Jefferis, G. S. X. E., Potter, C. J.. 2017-10-20. An olfactogenetic approach identifies olfactory neurons and brain centers directing negative oviposition decisions in Drosophila.. https://doi.org/10.1101/206342

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience